Sandra Lejniece

849 total citations
30 papers, 192 citations indexed

About

Sandra Lejniece is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Sandra Lejniece has authored 30 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Sandra Lejniece's work include Chronic Lymphocytic Leukemia Research (8 papers), Platelet Disorders and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Sandra Lejniece is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Platelet Disorders and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Sandra Lejniece collaborates with scholars based in Latvia, Germany and Italy. Sandra Lejniece's co-authors include Modra Murovska, Víctor Jiménez‐Yuste, Robert Klamroth, Aivars Lejnieks, Takashi Suzuki, Elena Santagostino, Svetlana Chapenko, F. Abdul Karim, Judi Møss and Trine Saugstrup and has published in prestigious journals such as Blood, Journal of Thrombosis and Haemostasis and Journal of Medical Virology.

In The Last Decade

Sandra Lejniece

28 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Lejniece Latvia 8 105 55 53 46 29 30 192
Caterina Stefanizzi Italy 10 177 1.7× 114 2.1× 62 1.2× 45 1.0× 14 0.5× 25 237
Ryosuke Shirasaki Japan 6 102 1.0× 26 0.5× 49 0.9× 24 0.5× 9 0.3× 33 156
Suguru Honda Japan 8 29 0.3× 32 0.6× 29 0.5× 100 2.2× 27 0.9× 14 170
Natalie Ertz-Archambault United States 4 42 0.4× 27 0.5× 45 0.8× 19 0.4× 10 0.3× 13 145
Laura Fogliatto Brazil 9 92 0.9× 132 2.4× 52 1.0× 29 0.6× 9 0.3× 32 218
Tülin Tuğlular Türkiye 7 93 0.9× 87 1.6× 18 0.3× 37 0.8× 11 0.4× 25 174
Elizaveta Belyaeva United States 5 39 0.4× 31 0.6× 34 0.6× 17 0.4× 17 0.6× 11 106
Brigitte Krummel-Lorenz Germany 3 52 0.5× 53 1.0× 20 0.4× 153 3.3× 27 0.9× 3 216
Witold Prejzner Poland 10 237 2.3× 218 4.0× 32 0.6× 135 2.9× 21 0.7× 33 320
Asu Fergün Yılmaz Türkiye 5 103 1.0× 40 0.7× 32 0.6× 8 0.2× 8 0.3× 20 147

Countries citing papers authored by Sandra Lejniece

Since Specialization
Citations

This map shows the geographic impact of Sandra Lejniece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Lejniece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Lejniece more than expected).

Fields of papers citing papers by Sandra Lejniece

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Lejniece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Lejniece. The network helps show where Sandra Lejniece may publish in the future.

Co-authorship network of co-authors of Sandra Lejniece

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Lejniece. A scholar is included among the top collaborators of Sandra Lejniece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Lejniece. Sandra Lejniece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lejniece, Sandra, et al.. (2023). Chylothorax: A Tangled Road to Definitive Diagnosis of Non-Hodgkin Lymphoma. American Journal of Case Reports. 24. e939098–e939098. 2 indexed citations
2.
Vasse, Marc, et al.. (2022). Establishing reference intervals for von Willebrand factor multimers. Journal of Medical Biochemistry. 41(1). 115–121. 4 indexed citations
3.
Lejniece, Sandra, et al.. (2021). Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report. American Journal of Case Reports. 22. e933031–e933031. 2 indexed citations
4.
Lejniece, Sandra, et al.. (2020). Progressive multifocal encephalopathy in a patient with non-Hodgkin follicular lymphoma. Experimental Oncology. 42(3). 238–241.
5.
Tiede, Andreas, Faraizah Abdul Karim, Víctor Jiménez‐Yuste, et al.. (2020). Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model. Haematologica. 106(7). 1902–1909. 12 indexed citations
6.
Lejniece, Sandra, et al.. (2020). Dickkopf-related protein 1 expression in bone marrow of multiple myeloma patients: correlation with bone disease and plasma cell malignancy type. Experimental Oncology. 42(4). 285–288. 3 indexed citations
7.
Szántó, Tímea, et al.. (2020). Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use. Journal of Medical Biochemistry. 40(2). 167–172. 8 indexed citations
8.
Lejniece, Sandra, et al.. (2019). Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79,524 patients from Latvia. Experimental Oncology. 41(4). 354–362. 6 indexed citations
9.
10.
Lejniece, Sandra, et al.. (2017). Klippel–Trenaunay–Weber syndrome with atypical presentation of hypersplenism and nephrotic syndrome: a case report. Journal of Medical Case Reports. 11(1). 243–243. 2 indexed citations
11.
Lejniece, Sandra, et al.. (2017). GENERIC IMATINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA: TWO YEARS’ EXPERIENCE IN LATVIA. Experimental Oncology. 39(2). 151–154. 7 indexed citations
12.
Skride, Andris, et al.. (2017). Pulmonary arterial hypertension in a patient treated with dasatinib: a case report. Journal of Medical Case Reports. 11(1). 362–362. 5 indexed citations
13.
Jiménez‐Yuste, Víctor, Sandra Lejniece, Robert Klamroth, et al.. (2014). The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A. Journal of Thrombosis and Haemostasis. 13(3). 370–379. 23 indexed citations
14.
Jiménez‐Yuste, Víctor, Sandra Lejniece, Robert Klamroth, Trine Saugstrup, & Judi Møss. (2013). The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots. Blood. 122(21). 4783–4783. 1 indexed citations
15.
Chapenko, Svetlana, et al.. (2012). Relationship between beta‐herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation. Journal of Medical Virology. 84(12). 1953–1960. 17 indexed citations
16.
17.
Murovska, Modra, et al.. (2011). Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.. PubMed. 33(2). 99–103. 5 indexed citations
18.
Lejniece, Sandra, Modra Murovska, Svetlana Chapenko, et al.. (2011). Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient.. PubMed. 33(4). 239–41. 7 indexed citations
19.
20.
Lejniece, Sandra, et al.. (2007). Natural clearance of hepatitis C virus in hemophilia patients. Medicina. 44(1). 15–15. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Stefanizzi Breakdown of academic impact, for papers by Ryosuke Shirasaki Breakdown of academic impact, for papers by Suguru Honda Breakdown of academic impact, for papers by Natalie Ertz-Archambault Breakdown of academic impact, for papers by Laura Fogliatto Breakdown of academic impact, for papers by Tülin Tuğlular Breakdown of academic impact, for papers by Elizaveta Belyaeva Breakdown of academic impact, for papers by Brigitte Krummel-Lorenz Breakdown of academic impact, for papers by Witold Prejzner Breakdown of academic impact, for papers by Asu Fergün Yılmaz
Rankless by CCL
2026